In October 2019, Johnson & Johnson (J&J) issued a voluntary recall of a single lot of its Baby Powder. The Food and Drug Administration (FDA), when testing one sample of that Baby Powder, had discovered sub-trace levels of asbestos, so J&J implemented the recall out…
The Food and Drug Administration (FDA) recently announced a recall of three lots of Mylan nizatidine capsules because tests indicated the presence of trace amounts of N-nitrosodimethylamine (NDMA). NDMA has been classified as a probable human carcinogen and is the same chemical that has recently…
Over the last several months, e-cigarette manufacturer JUUL has faced increasing scrutiny and pressure from the U.S. government, the FDA, and the courts for its connection to the epidemic of vaping among America’s youth. The FDA has sent the company warning letters over its marketing…
In September 2019, the U.S. Food and Drug Administration (FDA) warned healthcare providers and patients that ranitidine drugs, including brand-name Zantac, had been found to contain N-nitrosodimethylamine (NDMA), a probable human carcinogen. The warning sent ripples through the healthcare community, with patients rushing to their…
On December 18, 2019, the Food and Drug Administration (FDA) announced yet another generic ranitidine recall, this time implemented by Glenmark Pharmaceutical Inc. The company is pulling all prescription ranitidine tablets (150 mg and 300 mg) from the U.S. market because they may contain unacceptable…
Nine plaintiffs have jointly filed a new Zantac cancer lawsuit in the U.S. District Court for the District of New Jersey. The plaintiffs have named as defendants all Zantac manufacturers, including Boehringer Ingelheim Pharmaceuticals, Chattem Inc., GlaxoSmithKline, Pfizer, and the current manufacturer, Sanofi. All plaintiffs…
The FDA recently announced a Class 1 recall—the most serious type of recall—of Ethicon Echelon Flex Endopath surgical staplers. The devices may not work as expected, presenting a risk of serious injuries or even death. The company initiated the recall on October 3, 2019, which…
Two plaintiffs—one from New York and the other from Virginia—recently filed a new generic Zantac (ranitidine) class-action lawsuit in the U.S. District Court for the Southern District of New York. The plaintiffs claim that generic ranitidine manufacturer Perrigo Company put consumers at risk when selling…
Following a wave of Zantac and generic ranitidine recalls, a Colorado man has filed a new Zantac lawsuit against the manufacturers of the heartburn medication. The plaintiff alleges that he used Zantac for about 23 years, and as a result, developed bladder cancer. He filed…
For the past few months, the Centers for Disease Control (CDC), the U.S. Food and Drug Administration (FDA), and state health departments have been investigating a mysterious vaping-related lung illness that has sent over 2,000 people to the hospital and killed at least 39. At…